Photo: Figure created in biorender.comTeam Immuno-metabolic reprogramming during viral infection
We aim to understand metabolic reprogramming during viral infection using multi-omics system biology and experimental assays.
Lead: Ujjwal Neogi.
Close
The Systems Virology Lab – Ujjwal Neogi
The Systems Virology lab at Laboratory Medicine focuses on using systems biology and experimental approaches to understand the biology of host-pathogen interactions targeted towards the RNA viruses. The group aims to identify the components of the immune response that are required for natural immune protection and disease severity that can be translated into the future development of vaccine and antiviral strategies against emerging and re-emerging viruses.
Part of the Department of Laboratory Medicine
Photo: Figure created in biorender.com
Photo: Illustration created in BioRender.comTeam Innate immune responses during viral infections
We aim to understand common global interferon-stimulated gene (ISG) responses against different viruses can provide a novel avenue for viral antagonism.
Lead: Soham Gupta.
Photo: Getty ImagesTeam Innate immune system in infection, inflammation and cancer
We study the innate immune system in acute and chronic inflammatory diseases in children and adults.
Lead: Magdalini Lourda.
Photo: Getty ImagesConnection between metabolism and fatigue after Crimean-Congo Fever
A recent study published by researchers from Karolinska Institutet in collaboration with Sivas Cumhuriyet University, Turkey, sheds light on the connection between Crimean-Congo Haemorrhagic Fever Virus (CCHFV) infection and prolonged fatigue.
Photo: Soham GuptaNew insights into the cellular response to SARS-CoV-2 infection
The COVID-19 pandemic caused by the new coronavirus has created an unprecedented public health challenge globally. Little was known about how the infecting cells respond to the virus and how the virus hijacks the host cellular machinery. A study led by researchers at Karolinska Institutet published in Emerging Microbes & Infection gives new insights into the virus-host interplay enabling newer ideas to tackle the virus.
Photo: Gerd Altmann/Public DomainNew biomarker for severe COVID-19
During the pandemic, it has become evident that people with cardiovascular disease and obesity are at much higher risk of developing very severe, even fatal COVID-19 disease. Researchers at Karolinska Institutet have identified some metabolic processes that SARS-CoV-2 uses to attack lung tissue.
Staff and contact
Group leader
- Ujjwal NeogiSenior Lecturer | Docent
All members of the group
- Rui BenfeitasAffiliated to Research
- Marieke BoeckerAffiliated to Research
- Prem Prashant ChaudharyAffiliated to Research
- Mahmoud DarwishResearch Specialist
- Alejandra EscósAffiliated to Research
- Soham GuptaAssistant Professor
- Magdalini LourdaSenior Research Specialist
- Ujjwal NeogiSenior Lecturer | Docent
- Negin NikouyanResearch Assistant
- Sefanit RezenePhd Student
- Kamlendra SinghAffiliated to Research
- Vikas SoodAffiliated to Research
- Anoop Tholamplackil AmbikanPostdoctoral Researcher